Drug
Vinorelbine
Vinorelbine: highest development phase Phase 2, developed by Pierre Fabre, United Therapeutics. 3 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Pierre Fabre, United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Vinorelbine NCT03007992 | Phase 2 | Metastatic Breast Cancer |
| Vinorelbine NCT00215930 | Phase 2 | Carcinoma, Non-Small-Cell Lung |
| Vinorelbine NCT02585388 | Phase 2 | Breast Cancer |
Latest
No recent events.
Follow Vinorelbine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.